Researchers at the University of Maryland Baltimore County have identified USP15 as a promising new target for ovarian cancer treatment, which appears to rely on the enzyme for survival, division, and spread. Reducing USP15 levels makes cancer cells more sensitive to chemotherapy drugs, potentially leading to less harm to healthy cells.
A UMBC researcher is exploring the effects of two key HIV prevention drugs in colon tissue, seeking to understand why they work better for some people than others. The study aims to provide knowledge that could lead to better dosing strategies and improved formulations, making PrEP more effective.
Researchers in India have identified β-esterase as the primary enzyme involved in α-cypermethrin detoxification, showing increased reactivity in response to the insecticide. This finding suggests that mosquitoes can dramatically increase production of a particularly effective enzyme when exposed to a threat.
A specific region of Dicer must be activated to achieve proper cell division and reproduction, a discovery that sheds light on the regulation of this enzyme's critical role in both cancer biology and fertility. This finding opens new avenues for studying how small epigenetic changes contribute to disease.
Researchers identified a potential connection between photosynthetic strategy and dark inhibition levels, with C3 and CAM plants showing variable and elevated levels, respectively. The study aims to inform future efforts to engineer more efficient photosynthesis in crops.
Researchers discovered a 5,000-year-old bacterial strain in an underground ice cave that shows resistance to multiple modern antibiotics. The Psychrobacter SC65A.3 strain has over 100 resistance-related genes and can inhibit the growth of several major antibiotic-resistant superbugs.
Researchers at Northwestern University and Stanford University develop a new artificial metabolism that converts waste carbon dioxide into acetyl-CoA, a universal metabolite used by all living cells. The system, called Reductive Formate Pathway (ReForm), uses engineered enzymes to perform metabolic reactions never seen in nature.
Scientists at Leibniz-HKI discovered an enzyme called BurK that cleaves the toxic molecule malleicyprol in human pathogenic bacteria. This mechanism regulates toxin levels and renders it harmless to humans, offering a potential therapeutic approach for antibiotic-resistant infections.
Researchers from National University of Singapore develop two techniques to boost carob pulp's flavor, making it more appealing and sustainable than cocoa. The innovations aim to reduce the chocolate industry's dependence on cocoa and address climate change challenges.
Researchers have developed an innovative antibody-based enzyme switch called 'Switchbody', which is activated upon antigen binding. The switch's mechanism relies on a 'trap-and-release' process, offering new opportunities in diagnostics and therapeutics.
Researchers identified NUDT5 as a structural regulator that controls purine synthesis by physically restraining the key biosynthetic step. This mechanism may also explain cancer drug resistance and informs new therapeutic approaches for diseases caused by MTHFD1 deficiency.
Researchers have discovered an enzyme called PapB that can create tight rings in therapeutic peptides, enabling the creation of stronger, longer-lasting versions of GLP-1 medications. This enzymatic method offers a simpler alternative to traditional chemical methods and could improve the stability and effectiveness of these drugs.
A new AI-powered tool, EZSpecificity, can predict the best enzyme-substrate combination for various applications. The tool outperformed existing models in accuracy, especially for halogenase enzymes.
Researchers used NMR spectroscopy to capture enzyme dynamics, discovering a 'crossover loop' structure that plays a crucial role in catalyzing reactions. This new method promises unprecedented access to biomolecule mechanisms and potential pathologies.
A team of researchers, led by Bibek R. Karki, traced the evolutionary history of the PRPS enzyme complex to understand its functions and importance in cellular biochemistry. They found that all four enzymes are crucial for cell function and work together to form a large complex.
Scientists from the University of Bath have identified two new families of chemical compounds that inhibit alpha-methylacyl-CoA racemase (MCR) in Mycobacterium tuberculosis, a key enzyme for TB survival. This breakthrough could lead to new treatments for TB and potentially other diseases like prostate cancer.
The University of Illinois team created a user-friendly process to improve enzyme performance using AI and automated robotics. By predicting sequence changes and testing variants, they increased the activity of two key industrial enzymes by up to 26 times and 90 times.
A Kobe University team developed a technique to classify thousands of enzymes, allowing for rapid evaluation and identification of highly active and versatile enzymes. The approach enabled the discovery of an enzyme with up to 10 times higher productivity than industry standards.
Scientists have discovered a novel way to block an enzyme involved in regulating blood pressure, called ACE. Ciprofloxacin binds selectively to a different site, blocking angiotensin I but not inhibiting the enzyme's other functions.
Researchers used CRISPR interference to examine every gene in the human genome and discovered a new set of genes contributing to Parkinson's disease risk. The study identified the Commander complex, which regulates lysosomal function and is implicated in PD risk, offering opportunities for new treatments.
Researchers developed a bamboo-based microreactor system for efficient enzyme immobilization, demonstrating high transformation rates and thermal stability. The innovative use of bamboo nanofibers offers a sustainable alternative to traditional methods.
Cells employ a protein network to repress TE activity and keep themselves healthy. O-GlcNAc transferase (OGT) is a lead choreographer in this process, protecting cells from genomic instability by restraining TET activity.
PARP inhibitors have been found to be effective in treating cancers with BRCA1/2 mutations by blocking DNA repair pathways. The combination of PARPis with chemotherapeutic drugs can also improve treatment efficacy, increasing DNA damage and blocking repair processes.
Researchers at CCM Biosciences have discovered novel enzyme activators that fully restore the activity of Sirtuin-3, a master regulator of cellular energy production. These compounds hold significant potential for addressing age-related disorders such as Alzheimer's and Parkinson's diseases.
Researchers have identified two new deubiquitinases, USP53 and USP54, which play a crucial role in removing polyubiquitin tags from proteins. This study suggests that mutations in the USP53 gene are associated with paediatric cholestasis, highlighting the potential for targeted treatment.
A novel study found that the TPMT∗8 allele is associated with reduced metabolism of thiopurine drugs, which can lead to toxicity. The research emphasizes the importance of understanding the function of TPMT∗8 to ensure effective pharmacogenomic testing across all ancestries.
A scoping review found associations between myositis disease activity and gluten exposure in patients with inflammatory myopathies and celiac disease. The study suggests that gluten may act as an exogenous antigen driving myositis in genetically predisposed patients.
Researchers at Max Planck Institute developed a new, efficient metabolic pathway to convert acetyl-CoA into pyruvate, enabling effective CO2 utilization. The 'lactyl-CoA mutase' enzyme can produce valuable products like 3-hydroxypropionate for sustainable plastics.
Scientists have developed a novel enzyme, SUPer RNA EcoGII Methyltransferase (SUPREM), which can selectively modify RNA and has high methylation activity. This tool can be used to investigate RNA modifications in various diseases, providing new insights into their role in cell health.
Researchers at POSTECH have identified GLUT3 as essential for the suppressive function of regulatory T cells in tumor microenvironments, which can be targeted for cancer immunotherapy. The team's findings highlight the critical role of GLUT3 in regulating protein modifications that sustain immune suppression within tumors.
A team at Penn State developed an experimental pipeline called Cleavage High-Throughput Assay (CHiTA) that can test the activity of thousands of predicted twister ribozymes. The study identified approximately 94% of tested ribozymes as active, revealing their function can persist even with slight imperfections.
Scientists have discovered a natural compound called sulfuretin that can halt the progression of certain forms of cancer and demyelinating conditions like multiple sclerosis. The study found that sulfuretin blocks the activity of an enzyme involved in these diseases, suggesting its potential as a treatment.
Researchers discovered a gene-mutation pathway that can lead to targeted therapies for blood cancers. The TET2 gene's enzymatic activity regulates chromatin state and leukaemogenesis, providing new therapeutic targets.
A team of researchers has identified mangrove bacteria that can transform polyethylene terephthalate (PET) particles, which are a major contributor to ocean pollution. The discovery of novel enzymes and bacterial species with the ability to break down PET could potentially be used to develop new strategies for plastic waste cleanup.
The red milkweed beetle's genome has been sequenced, providing insights into how it safely feeds on toxic plants. The study found an apparent expansion of genes related to toxin sequestration and metabolic enzymes.
Research shows that parvalbumin-expressing neurons in the cerebral cortex activate when sleepiness increases, leading to rebound sleep. The activation of CaMKII protein causes rebound sleep by activating these neurons. This study sheds light on the molecular and neural mechanisms of sleep homeostasis.
Researchers developed a strategy to identify new antimicrobial drugs with therapeutic promise from bacterial datasets. PHAb10 and PHAb11 showed robust antibacterial activity against various bacterial species, including those resistant to traditional antibiotics.
A team from the University of Illinois has developed a modeling framework connecting enzyme activity related to photosynthesis to yield. This breakthrough model ties dynamic photosynthetic pathways directly to crop growth for the first time.
Researchers at Hokkaido University have developed a comprehensive derivative synthesis method to find new antimicrobial drugs. They identified eight analogs possessing strong MraY inhibitory and antibacterial activity, with one showing promising effectiveness in mouse infection models.
Researchers investigate chemical modifications to genetic regulation mechanisms, finding that Set8 controls gene activity through a mechanism other than histone modification. This study refines our understanding of genetic regulation relevant to human diseases like cancer.
Researchers isolated three bacterial strains that produce amylase enzymes from sugar factory waste, showing great potential for production. The optimal conditions for amylase production were found to be 37°C and pH 7.0, leading to increased enzyme activity.
Researchers have discovered that the Greenland shark's metabolism remains unaltered over time, suggesting a key role in its exceptional longevity of at least 270 years. The study also found that metabolic enzymes were more active at higher temperatures, challenging previous assumptions about the species' adaptation to cold environments.
Researchers found that inhibiting telomerase, an enzyme related to cell growth and division, can suppress abnormal vascular growth in the retina. This discovery provides a potential alternative treatment option for wet AMD, which is currently treated with anti-VEGF injections.
Researchers at Purdue University have developed a patent-pending compound called HSN748 to treat drug-resistant acute myeloid leukemia (AML). The compound has been validated in tests with IU School of Medicine and demonstrated 100% survivability after 120 days. AML is a cancer that begins in bone marrow and can be difficult to treat du...
Researchers have identified a potent and unique way to kill drug-resistant bacteria using a repurposed compound called LEI-800. The compound targets the bacterial enzyme DNA gyrase, which is essential for bacterial growth and has not been targeted by existing antibiotics.
Essential oils have been shown to possess significant bioactive components with therapeutic potential, influencing various industries such as food, cosmetics, and pharmaceuticals. Their antioxidant, antimicrobial, and anti-inflammatory properties make them valuable in managing diseases like cancer, Alzheimer's, and diabetes.
Scientists at Boyce Thompson Institute have developed a method to enhance Rubisco production in maize, increasing carbon assimilation and boosting plant height. The transgenic plants also showed improved resilience to chilling stress, maintaining higher photosynthetic rates during cold exposure.
Scientists at Sanford Burnham Prebys and Vanderbilt University have identified phosphatidylinositol-5-phosphate 4-kinases (PI5P4Ks) as a key regulator of the hippo pathway, which is dysregulated in cancer. The study suggests that targeting PI5P4Ks may lead to new treatments for cancers with abnormal hippo signaling.
Bromination of extracellular matrix proteins is a physiological modification dependent on peroxidasin, revealing a possible role for protein bromination in pulmonary fibrosis and non-fibrotic lung tissue. This study extends knowledge of halogenation's importance in the mammalian organism.
Researchers at Kobe University have discovered a new method to inhibit streptococcal infections by using aggregates of the non-toxic molecule Mn007. The study found that aggregates of Mn007 significantly reduce bacterial growth, suggesting potential as an effective treatment for toxic shock syndrome.
Researchers at UVA Health discovered a potential explanation for long COVID symptoms by identifying 'abzymes' that act like enzymes regulating important bodily functions. This discovery could lead to new treatments targeting these rogue antibodies to alleviate acute effects of COVID-19 and its complications.
Researchers have identified PDE4B as a potential target for treating Alzheimer's disease, where reducing its activity shows promise in improving memory and glucose metabolism. The study suggests that this approach may also protect against other forms of dementia, such as Huntington's disease.
Researchers unveil innovative strategies to overcome metabolic constraints in CAR-T cell therapy, aiming to boost its efficacy in treating solid tumors. Metabolic interventions targeting immunosuppressive metabolites, metabolite uptake, and mitochondrial metabolism are proposed to enhance anti-tumor activity.
A UNIGE team has identified the mechanism of action of PARP inhibitors, used to treat breast and ovarian cancer. By blocking one activity while preserving another, these inhibitors can maintain toxic effects on cancer cells while sparing healthy cells.
A new nanocarrier has been developed that can selectively release drugs in cancer cells through controlled endosomal escape. The approach exploits the unique enzymatic activity of cancer cells, allowing for targeted delivery and reduced harm to healthy cells.
SourceWiley·JournalAngewandte Chemie International Edition·TypeExperimental study·DateFeb 28, 2024
Researchers developed a portable, droplet-based millifluidic device to monitor patients in the critical first days after surgery. The device measures drainage fluid's alpha-amylase activity in real time, reducing test duration from six hours to two minutes.
The discovery reveals that microbes can conjugate bile acids beyond glycine and taurine, increasing diversity and function of bile acids. This challenges scientific dogmas and raises questions about the role of bacteria in gut health.
A recent study published in Nature Plants reveals that O-glycosylation of the transcription factor SPATULA promotes Arabidopsis style development. The experimental study sheds new light on the mechanisms underlying plant organ symmetry.
Scientists discovered how methanogenic archaea regulate nitrogen uptake using a molecular switch that adjusts enzyme activity based on 2-oxoglutarate levels. This regulation prevents energy waste when cells have enough nitrogen.
Researchers at Nagoya University have discovered a relationship between ALS progression and the disruption of mitochondria-associated membranes (MAM) and TBK1 activity. Decreased activation of TBK1 is linked to motor neuron death in ALS patients and mice with disrupted MAM.